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K e y  M e s s a g e s 
1. Adrenomedullin augments the production 
of interleukin-10, a cytokine that limits 
inflammation.
2. Interferon-γ, a cytokine that is increased in 
inflammation, downregulates the receptor and 
binding protein of adrenomedullin. 
3. Cyclic AMP mediates the increased expression 
of adrenomedullin, interleukin-6, and 
interleukin-10 in response to endotoxin.
4. The production of interleukin-6 is mediated by 
p38-mitogen-activated protein kinase (MAPK), 
p42/44-MAPK, protein kinase C, and protein 
Modulation of cytokine responses by 
adrenomedullin and adrenomedullin binding 
protein-1 in macrophages: a novel pathway  
in sepsis
Introduction
Polymicrobial sepsis is a life-threatening disorder. 
Patients die of septic shock and multiple organ 
failure caused by lipopolysaccharide (LPS) and 
other bacterial products. A hyperdynamic phase 
is followed by shock and circulatory collapse. 
Myocardial dysfunction frequently accompanies 
severe sepsis and septic shock secondary to 
circulating depressant factors, including tumour 
necrosis factor-alpha (TNF-α) and interleukin-1 beta 
(IL-1β). Macrophages produce proinflammatory 
cytokines including TNF-α, IL-1β, and IL-6 that lead 
to tissue injury.
 Adrenomedullin (AM) is a vasorelaxant 
peptide originally isolated from the adrenal medulla. 
It relaxes vascular smooth muscle cells through 
the elevation of intracellular cyclic adenosine 
3’-5’-monophosphate (cAMP).1 It also acts on 
endothelial cells by activating adenylyl cyclase 
and nitric oxide synthase, resulting in dilation of 
blood vessels. The macrophage produces AM in 
inflammation and sepsis. Transgenic mice over-
expressing AM are resistant to septicaemic shock. 
AM markedly increased IL-6 production in both 
resting and LPS-stimulated macrophages, but 
significantly suppressed LPS-induced TNF-α 
secretion.2 IL-6 and IL-10 can inhibit the production 
of pro-inflammatory cytokines such as TNF-α and 
IL-1. These results suggest that AM may play an 
important role as an anti-inflammatory regulator 
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of the inflammatory response in the macrophages, 
at least partly, via its effect on production of 
inflammatory cytokines. 
 Elevated levels of AM play a major role in 
initiating the hyperdynamic response during the 
early stage of sepsis, yet transition to the late, 
hypodynamic phase occurs, despite continued high 
circulating levels of AM.3 A specific AM binding 
protein-1 (AMBP-1) carries AM in human plasma 
and is complement factor H.4 The decreased vascular 
response to AM in advanced sepsis is related to 
a decrease in AMBP-1. Administration of AM/
AMBP-1 to septic animals prevents the drop in blood 
pressure and reduces mortality. AM and AMBP-1 
in combination down-regulate pro-inflammatory 
cytokines in septic animals, and suppress LPS-
induced TNF-α expression and release from the 
macrophages.5 
 The interaction between AM and AMBP-1 has 
opened a new avenue for research into the transition 
from the hyperdynamic to the hypodynamic phase 
of sepsis. AM has been reported to induce its effect 
through the cAMP-, Ca2+, or mitogen-activating 
protein kinase (MAPK) mediated pathway. 
Expression of AMBP-1 is detectable in both 
monocytes and macrophages, and AMBP-1 given 
in conjunction with AM further raises AM-induced 
cAMP production. Nonetheless, little is known about 
the regulation of AMBP-1, the cause of reduced 
AMBP-1 production in sepsis, or the regulatory 
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
kinase K, whereas that of interleukin-10 is 
mediated by p38-MAPK and protein kinase K.
5. These downstream pathways could be targets for 
therapeutic intervention.
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pathways involved to elicit the physiological actions 
of AM and AMBP-1. 
 The study aimed to (1) investigate the expression 
of AM, AMBP-1 and AM receptor proteins in 
the LPS-induced inflammatory response in a rat 
alveolar macrophage cell line; (2) examine the effect 
of AM and AMBP-1 on LPS-induced inflammatory 
cytokine production in macrophages and determine 
whether feedback loops or desensitisation of AM 
receptors affect the production of AM and AMBP-1; 
and (3) identify a potential role of second messenger-
dependent kinases in the regulation of AM and 
AMBP-1 expression and AM-induced cytokine 
responses in LPS-stimulated macrophages.
Methods
This study was conducted from October 2006 
to March 2008. NR8383 rat macrophages were 
stimulated by IFN-γ, TNF-α, IL-6, and IL-10 with 
or without LPS (at 1 to 1000 ng/mL) for 6 and 24 
hours.2,6 Levels of AM, AMBP-1, and AM receptor 
proteins (calcitonin receptor-like receptor [CRLR]) 
and receptor activity-modifying protein (RAMP2 
and RAMP3) mRNA were quantified using real-time 
PCR (ABI PRISM Sequence Detection System 7000, 
Applied Biosystems Group) or semi-quantitative 
RT-PCR after reverse transcription. Immunoreactive 
AM was measured by a radioimmunoassay (Phoenix 
Pharmaceutics, Belmont, CA, USA).
 NR8383 rat macrophages and human 
monocytic cell line THP-1 were studied. THP-1 cells 
were incubated with 100 nM phorbol 12-myristate 
13-acetate (PMA, Sigma, USA) for 72 hours to induce 
differentiation into macrophage-like cells. The cells 
were stimulated by LPS (10 ng/mL) and AMBP-1 
(500 nM) in the presence or absence of AM or AM 
receptor antagonists (AM22-52 or CGRP8-37) for 6 and 
24 hours. Concentrations of TNF-α, IL-6, and IL-10 
in the culture supernatants were measured using 
enzyme-linked immunosorbent assays (ELISA, R&D 
Systems, USA). To study desensitisation of the AM 
receptor, cells were pre-incubated with AM (1 to 
1000 nM) for 2 hours followed by a washout period 
and a re-stimulation by LPS with or without AM/
AMBP-1. The concentration of TNF-α, IL-6, and 
IL-10 in the supernatant was measured.
 NR8383 macrophages were stimulated by 
LPS (10 ng/mL) with or without addition of AM, 
forskolin (an adenylyl cyclase activator), SQ22536 
(Qbiogene, an adenylyl cyclase inhibitor) or 
dibutyril-cAMP (a membrane permeable cAMP 
analogue) or a signalling pathway inhibitor for 6 and 
24 hours. Inhibitors of protein tyrosine kinase (PTK) 
(genistein, Merck, USA), p38 and p42/44 MAPK, 
protein kinase A (PKA), and protein kinase C (PKC) 
were used. TNF-α, IL-6, and IL-10 in the supernatant 
were measured. 
 Changes in cytokine levels were analysed using 
analysis of variance or t-test as appropriate. A P value 
of <0.05 was considered significant. 
Results
Expression of AM, AMBP-1, and AM 
receptor proteins in the LPS-induced 
inflammatory response in a rat alveolar 
macrophage cell line
In unstimulated NR8383 cells, AMBP-1 was 
constitutively expressed, with a RT-PCR cycle 
threshold of 26.62±0.08 compared with 18.35±0.07 
for β-actin. Basal mRNA expression of CRLR and 
RAMP-2 were low, with a mean RT-PCR cycle 
threshold of 30.77±0.03 and 35.52±0.07, respectively, 
compared with 18.35±0.07 for β-actin. 
 LPS increased expression of CRLR by 5- to 
26-fold at 6 hours (P<0.01), which declined to 5- to 
11-fold above basal at 12 hours and to 2- to 4-fold 
above basal at 24 hours. IFN-γ, TNF-α, IL-6, or IL-10 
had no effect on CRLR mRNA level in unstimulated 
NR8383 cells. In 10 ng/mL LPS-stimulated cells, 
IL-10 and IFN-γ reduced CRLR mRNA level at 6 
hours from 12.2-fold basal level to 8.0-fold and 5.6-
fold, respectively (P<0.05), whereas IL-6 increased 
the CRLR mRNA level to 16.9-fold (P<0.05). LPS 
reduced RAMP-2 expression to 0.35-fold basal level 
at 6 and 12 hours. 
 AMBP-1 expression was not altered by LPS, 
but IFN-γ significantly reduced AMBP-1 mRNA 
level in unstimulated and LPS-stimulated cells to 
0.66-fold and 0.47-fold of basal level, respectively, at 
6 hours (Fig 1). 
 IFN-γ at 10 ng/mL increased AM 
concentration in the culture medium from 12.9±2.3 
fmol/mL to 215.9±35.7 fmol/mL (P<0.05), whereas 
addition of IFN-γ to LPS-stimulated cells increased 
AM concentration from 120.6±23.8 fmol/mL to 
329.7±58.4 fmol/mL (P<0.05).
Effect of AM and AMBP-1 on inflammatory 
cytokine production in NR8383 and PMA-
activated THP-1 cells
AMBP-1 at 500 nM did not alter the concentration of 
TNF-α, IL-6, or IL-10 in LP-stimulated macrophages. 
IL-10 secretion from unstimulated NR8383 cells 
was undetectable and not increased by AM. LPS 
stimulated IL-10 production that was augmented by 
100 nM AM (Fig 2a).
 PCR products of IL-10 and TBP are shown (Fig 
2b). IL-10 mRNA expression was significantly up-
regulated at 6 hours after LPS, paralleled the IL-10 
peptide levels and further increased by 140%, 120%, 
and 65%, with addition of exogenous AM for LPS 
at 1, 5, and 100 ng/mL, respectively (Fig 2c). LPS-
induced IL-10 production was also increased by 
TNF-α and IL-6 by 71% and 70%, respectively, but 
was markedly reduced by IFN-γ by 82% (Fig 2d). 
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 In PMA-activated THP-1 cells, LPS markedly 
increased IL-10 production from as low as 1 ng/
mL. 100 nM AM increased LPS-induced IL-10 
production by 69% to 112% while IFN-γ reduced it 
by 77%. 
 The AM receptor antagonists (AM22-52 and 
CGRP8-37) did not significantly alter the concentration 
of TNF-α, IL-6, or IL-10. Pre-incubation with AM 
followed by washout had no effect on TNF, IL-6, or 
IL-10 production, compared with LPS stimulation 
alone. 
Role of second messenger-dependent kinases 
in the regulation of AM expression and 
AM-induced cytokine responses in LPS-
stimulated macrophages
Dibutyril-cAMP (10 μM) and forskolin (1 μM) 
reduced TNF-α production by 50% and increased 
the production of IL-6 and IL-10 by 105% to 128%. 
Dibutyril-cAMP also increased AM concentration 
from 120.6±23.8 fmol/mL to 514.5±102.6 fmol/mL 
(P<0.05). SQ22536 had no effect on IL-6, IL-10, or 
AM concentration.
 SB203580 inhibited LPS-induced IL-10 
production by 56%; the production was partially 
reversed by exogenous AM and IL-6 but not TNF-α 
(Fig 3a). In contrast, PD98059 did not significantly 
affect IL-10 production that could be increased 
by adding AM or IL-6 (Fig 3b). SB203580 reduced 
IL-6 production by 13% to 29%; the produciton was 
completely reversed by adding AM or TNF-α (Fig 
3c). PD98059 reduced IL-6 production by 22% to 
26%; the production was reversed by AM but not 
TNF-α (Fig 3d). 
 In PMA-activated human THP-1 cells, 
PD98059 had no effect on LPS-induced IL-10 
production but SB203580 inhibited it by 66%. This 
blockade was not reversible by AM, TNF-α, or IL-6. 
 PKA-inhibitor did not significantly affect IL-6 
and IL-10 production. PKC-inhibitor reduced IL-6 
production by 32% (P<0.05), but did not alter IL-10 
production. Genistein reduced both IL-6 and IL-10 
production by 87%. IL-6 production was partially 
restored by exogenous AM, but IL-10 production 
was not rescued by AM, TNF-α, or IL-6.
Discussion
In this study, LPS increased the initial expression 
of CRLR but reduced the expression of RAMP-2. 
Expression of CRLR in LPS-stimulated cells was 
attenuated by IL-10. This might suggest a negative 
feedback or dampening effect of IL-10 on CRLR 
expression. IFN-γ increased AM production in LPS-
stimulated cells, while it reduced both CRLR and 
AMBP-1 expression. 
 In this study, AM significantly augmented LPS-
induced IL-10 production in both NR8383 alveolar 
macrophages and PMA-activated THP-1 cells. This 
indicates a role of AM production in macrophages 
and ‘macrophage-like’ cells. On the contrary, AM 
receptor antagonists had no significant effect on the 
production of these inflammatory cytokines on LPS-
stimulated NR8383 cells. These indicate that other 
mediators or alternative pathways independent 
of AM may be sufficient to stimulate the IL-10 
production in these cells. Furthermore, IFN-γ 
reduced LPS-induced IL-10 production in both 
NR8383 alveolar macrophages and PMA-activated 
THP-1 cells that might be related to its inhibitory 
effect on the AM receptor and AMBP-1 expression. 
Thus, AM and IFN-γ might have opposite roles in 
the regulation of the anti-inflammatory cytokine 
IL-10 in both rat and human macrophages.
 In this study, cAMP mediated the increased 
expression of AM, IL-6 and IL-10, and the decreased 
expression of TNF-α following LPS stimulation. 
Moreover, the production of IL-6 was mediated 
by p38-MAPK, p42/44-MAPK, PKC, and PTK, 
whereas that of IL-10 was mediated by p38-MAPK 
and PTK. Activation of the p42/44- and p38- MAPK 
pathways is common early signals necessary for 
LPS-induced cytokine production in monocytes and 
macrophages.7 
 In this study, blockade of the p38-MAPK 
pathway by SB203580 could be reversed by 
exogenous AM and IL-6, suggesting that other 
FIG 1.  Relative expression of adrenomedullin-binding protein-1 (AMBP-1) in 
NR8383 cells in response to lipopolysaccharide (LPS) and inflammatory mediators 
at 6 hours
NR8383 cells were stimulated by different inflammatory mediators in the presence 
or absence of LPS. Expressions of AMBP-1 mRNA were measured by real-time PCR 
at 6 hours of incubation 
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FIG 2.  Effect of adrenomedullin (AM) and inflammatory mediators on lipopolysaccharide (LPS)-induced IL-10 production in 
NR8383 cells
(a) NR8383 cells were stimulated with LPS in the presence or absence of exogenous AM at 100 nM. IL-10 concentrations in the 
culture media were measured at 6, 12, and 24 hours by ELISA. (b) Representative results of gene-specific PCR products of IL-10 
and TBP mRNA at 6 hours of incubation analysed by gel electrophoresis. (c) Semi-quantitative RT-PCR analysis was performed to 
determined IL-10 mRNA expression after normalising with TBP mRNA level at 6 hours after LPS-stimulation. (d) NR8383 cells were 
stimulated with 1 ng/mL of LPS in the presence or absence of AM (at 100 nM) or TNF-α, IL-6, and IFN-γ (each at 30 ng/mL). IL-10 
concentrations were measured at 24 hours of incubation 
* P<0.05, vs LPS alone
† P<0.01, vs LPS alone
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pathways may exist to induce IL-10 production 
upon LPS-stimulation. LPS-induced IL-10 and IL-6 
production were markedly reduced by genistein, 
indicating that PTK-mediated pathways play an 
important role. The fact that IL-10 synthesis could 
not be rescued by any of the mediators that increase 
IL-10 production indicates a decisive role of PTKs 
in IL-10 production in this macrophage cell line. In 
contrast, IL-6 production could be partially rescued 
by AM in the presence of genistein, suggesting that 
AM activates more than one pathway to induce IL-6 
production. 
Conclusions
IFN-γ increases the expression of AM but 
downregulates CRLR and AMBP-1. AM augments 
LPS-induced IL-10, independently of increases in 
TNF-α and IL-6, and acts in opposition to IFN-γ. 
cAMP mediates the increased expression of AM, 
IL-6, and IL-10, and the decreased expression of 
TNF-α following LPS stimulation. The production of 
IL-6 is mediated by p38-MAPK, p42/44-MAPK, PKC 
and PTK, whereas that of IL-10 is mediated by p38-
MAPK and PTK. AM plays a role in the regulation 
of inflammation. It augments the production 
of IL-10, a cytokine that limits inflammation. 
Nonetheless, the effectiveness of AM, although 
elevated in inflammation, may be diminished by 
IFN-γ that down-regulates AM’s receptor and its 
binding protein. The downstream pathways that 
FIG 3.  Effect of SB203580 and PD98059 inhibitors of p38- and p42/44-MAPKs on lipopolysaccharide (LPS)-induced production of IL-10 and IL-6 in 
NR8383 cells*
NR8383 cells were pretreated with SB203580 (2.5 μM) or PD98059 (25 μM) for 1 hour before stimulation with LPS (1 ng/mL) in the presence or 
absence of exogenous AM (100 nM), TNF-α or IL-6 (each at 30 ng/mL). (a) and (b) IL-10 concentrations in culture media were measured by ELISA at 24 
hours of incubation. (c) and (d) IL-6 concentrations at 6 and 24 hours after stimulation were measured by ELISA 
* Untr denotes untreated sample with 0.05% DMSO but no inhibitor added for pretreatment prior to LPS stimulation; Ctr denotes control pretreated 
with inhibitor and stimulated with LPS alone; AM, TNF-α, and IL-6 denote samples pretreated with inhibitor and co-stimulated with LPS and AM, TNF-α, 
or IL-6, respectively. 
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mediate IL-10 and IL-6 production are identified. 
These findings suggest new targets for therapeutic 
intervention. 
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